Literature DB >> 148778

Identification of soluble fibrinogen fibrin monomer complexes by non-enzymatic polymerisation in the tissue.

U Bleyl, P Rieger, J A Rossner.   

Abstract

In states of plasmic hypercoagulability and consumption coagulopathy ethanol favours the non-enzymatic polymerization of circulating soluble fibrinogen fibrin monomer complexes (FFMC) in vitro. The ethanol-gelation test of Godal and Abildgaard makes use of this phenomenon, called paracoagulation. The present studies show that it is also possible to visualize soluble FFMC by means of ethanol-gelation. In the electron microscope, FFMC, polymerized non-enzymatically by ethanol in the spleen, are characterized by plump or slender mycelioid fibrillar precipitates that show a uniform rhythmic transverse striation, a period-coincidental filamentary arrangement and an average periodicity of 23 nm. The ultrastructure demonstrates these ethanol-induced filaments to be in vitro-polymerized fibrin monomer derivatives. Paracoagulation with ethanol allows the identification of soluble FFMC in the tissue prior to the formation of highly polymerized fibrin-rich microthrombi, the established equivalents of the DIC-syndrome. The electron microscope studies also show the existence of a second type of fibrillary structure in the tissue polymerized by ethanol. This second type lacks the characteristic periodicity of fibrin and the period-coincidental arrangement of the filamentary structures, but is characterized by closely packed or chain-like aligned, irregularly sized spherical bodies. There is some evidence that these spherical bodies in vitro represent non-enzymatically polymerized complexes of fibrin monomers and fibrin degradation products (FDP), the equivalent of a limited local or generalized fibrinolysis in vivo.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 148778     DOI: 10.1007/bf00427187

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  18 in total

Review 1.  Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.

Authors:  V J Marder; A Z Budzynski
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

2.  Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test.

Authors:  B Lipiński; K Worowski
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

3.  The fine structure of fibrin.

Authors:  D Kay; B J Cuddigan
Journal:  Br J Haematol       Date:  1967-05       Impact factor: 6.998

4.  An electron microscope study of the polymerization of fibrinogen and its derivatives.

Authors:  G J Stewart
Journal:  Scand J Haematol Suppl       Date:  1971

5.  Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products.

Authors:  M Furlan; E A Beck
Journal:  Biochim Biophys Acta       Date:  1972-05-18

6.  [Reticuloendothelial clearance of intravascular fibrin monomers in the spleen].

Authors:  U Bleyl; W Kuhn; H Graeff
Journal:  Thromb Diath Haemorrh       Date:  1969-08-31

7.  Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.

Authors:  B Lipinski; Z Wegrzynowicz; A Z Budzynski; M Kopeć; Z S Latallo; E Kowalski
Journal:  Thromb Diath Haemorrh       Date:  1967-02-28

8.  Globular hyaline microthrombi--their nature and morphogenesis.

Authors:  U Bleyl; J A Rossner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-05-03

9.  Stable complex of fibrinogen and fibrin.

Authors:  T Sasaki; I H Page; J R Shainoff
Journal:  Science       Date:  1966-05-20       Impact factor: 47.728

10.  Plasmic degradation of human fibrinogen. IV. Identification of subunit chain remnants in fragment Y.

Authors:  M Furlan; T Seelich; E A Beck
Journal:  Biochim Biophys Acta       Date:  1975-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.